USP22 and neoplasm: To further explore the molecular mechanisms by which USP22‐mediated tumor cell‐derived EVs promote tumor metastasis in LUADs, we identified KDELR1 as a downstream effector of USP22 using gene chip and bioinformatics analyses (Figure 5).